Advertisement
Singapore markets close in 7 hours 56 minutes
  • Straits Times Index

    3,187.66
    +32.97 (+1.05%)
     
  • Nikkei

    37,358.68
    -721.02 (-1.89%)
     
  • Hang Seng

    16,385.87
    +134.03 (+0.82%)
     
  • FTSE 100

    7,877.05
    +29.06 (+0.37%)
     
  • Bitcoin USD

    62,737.40
    +1,180.02 (+1.92%)
     
  • CMC Crypto 200

    1,302.64
    +417.10 (+46.64%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • Dow

    37,775.38
    +22.07 (+0.06%)
     
  • Nasdaq

    15,601.50
    -81.87 (-0.52%)
     
  • Gold

    2,393.00
    -5.00 (-0.21%)
     
  • Crude Oil

    82.60
    -0.13 (-0.16%)
     
  • 10-Yr Bond

    4.6470
    +0.0620 (+1.35%)
     
  • FTSE Bursa Malaysia

    1,544.76
    +4.34 (+0.28%)
     
  • Jakarta Composite Index

    7,166.81
    -7,130.84 (-49.87%)
     
  • PSE Index

    6,523.19
    +73.15 (+1.13%)
     

Merck’s Inorganic Growth Strategy in 2019

Merck’s Inorganic Growth Strategy in 2019

On April 2, Merck & Co. issued a press release announcing the successful completion of its cash tender offer for Immune Design, with 86.75% of the target’s total outstanding common stock tendered on a fully diluted basis.